BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 25/05/2023

FDA Clears Levobupivacaine Injection for Sale

The FDA has determined that Chirocaine (levobupivacaine) injection, 2.5mg/mL, 10mL and 30mL vials, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for approval of abbreviated new drug applications for these products.

Source: Federal Register — Food and Drug AdministrationOpen original release →